GE HealthCare Technologies Overview
GE HealthCare Technologies (GEHC) has a ROE of 14.51%, above the sector sector average of -6.13%.
Get informed when a big investor buys or sells
+ Follow14.51%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for GEHC is 14.51%. That is above the sector sector average of -6.13%. Investors often review this figure alongside GE HealthCare Technologies's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, GEHC currently prints 14.51% for ROE, while the sector average sits near -6.13%. That is roughly 336.7% above the sector mean. Large gaps often invite a closer look at GE HealthCare Technologies's growth, margins, and balance sheet.
Return on Equity shows how effectively GE HealthCare Technologies converts resources into returns. At 14.51%, GEHC may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting GEHC's ROE (14.51%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
